The Department of War is issuing a Request for Quotation to obtain quotes for specific pharmaceutical agents, with the goal of awarding Uniform Formulary Blanket Purchase Agreements and Additional Discount Program Agreements. The Pharmacy and Therapeutics Committee will review several specified drug classes, including Cardamyst and Pivya, in May 2026. A pre-quotation teleconference is scheduled for March 11, 2026. Clinical question responses must be submitted via email by a deadline specified within the RFQ documents. The attached RFQ contains all instructions, appendices, and points of contact.

The Department of War is issuing this Request for Quotation to obtain quotes for specific pharmaceutical agents, with the goal of establishing agreements for its pharmacy benefits program. The performance of services is not tied to a specific geographic location. A pre-quotation teleconference is scheduled for March 11, 2026. Clinical question responses must be submitted via email by a deadline specified within the RFQ documents. The drug classes under review for May 2026 include Cardamyst, Myqorzo, Ontralfy, Pivya, Sdamlo, Vybrique, and Zycubo.